Skip to main content

United States v. Lazaro Hernandez


United States v. Lazaro Hernandez
Court Docket No.: 22-CR-60129

Court Assigned: This case is assigned to U.S. District Judge Raag Singhal, U.S. District Court for the Southern District of Florida, U.S. Federal Building and Courthouse, 299 East Broward Boulevard, Courtroom 108, Fort Lauderdale, Florida 33301

Latest update: 

On June 15, 2023, defendant Lazaro Hernandez was sentenced to 180 months of imprisonment to be followed by three years of supervised release.

restitution hearing has been scheduled for September 12, 2023 at 2:00 PM at Fort Lauderdale Division, United States District Court, 299 East Broward Boulevard, Room 108, Fort Lauderdale, FL 33301 before Judge Raag Singhal.

Previous events: 

On April 6, 2023, defendant Lazaro Hernandez pled guilty.

On July 15, 2022 defendant Hernandez was arraigned before the Miami Duty Magistrate Judge in the Miami Division.

Criminal Charges: On June 10, 2022, Lazaro Hernandez, a resident of Miami-Dade County, Florida and the beneficial owner, operator, and agent of Allsource Medical LLC, RSNE LLC, AIA Wholesale LLC, Gentk LLC, and My Meds LLC, was charged by indictment with conspiracy to introduce adulterated and misbranded drugs and to defraud the United States, conspiracy to traffic in pre-retail medical products with false documentation, conspiracy to commit money laundering, and specific money laundering offenses.

According to the indictment, Lazaro Hernandez, 51, of Miami, was allegedly part of a nationwide scheme to defraud the U.S. Food and Drug Administration (FDA) and illegally distribute more than $230 million in adulterated and misbranded prescription drugs that were dispensed to unsuspecting patients. As alleged in the indictment, Hernandez acquired large quantities of prescription drugs, primarily HIV medication, illegally and then created false drug labeling and other documentation to make it appear as though these high-priced drugs had been obtained legitimately. To carry out the scheme, Hernandez and co-conspirators established licensed wholesale drug distribution companies in Florida, New Jersey, Connecticut, and New York (named above).  Hernandez and his co-conspirators used those companies to sell the adulterated drugs at steep discounts to other co-conspirators at wholesale pharmaceutical distributors in Mississippi, Maryland, and New York. Those wholesale pharmaceutical distributors then resold the drugs to pharmacies throughout the country, which billed the drugs to health insurers, including Medicare, and dispensed the adulterated and misbranded HIV medication to unsuspecting patients.

The indictment further alleges that Lazaro Hernandez and his co-conspirators unlawfully enriched themselves by selling and distributing adulterated, misbranded and diverted drugs as if they had been acquired through the legitimate channels of distribution in the pharmaceutical market.

For more information about the charges in this case, please see below:


Press Release

Victim Impact Statement:  If you would like to submit a Victim Impact Statement, you may do so by mailing the Victim Impact Statement below (or a letter to the court) to: Victim Witness Unit, U.S. Department of Justice, Criminal Division, Fraud Section, 10th & Constitution, NW,  Bond Building, Room 4416, Washington, D.C. 20530. You also may submit the Victim Impact Statement via email at or by fax at: (202) 514-3708. 

Victim Impact Statement (PDF)

The information on this website will be updated as new developments arise in the case. If you have any questions, please call the Victim Assistance Line toll-free at (888) 549-3945 or email us at

Presumption of Innocence: It is important to keep in mind that a criminal complaint is merely an allegation, and defendants are presumed innocent until proven guilty and that presumption requires both the court and our office to take certain steps to ensure that justice is served.

Crime Victims’ Rights Act and Right to Retain Counsel: The Crime Victims’ Rights Act (18 U.S.C. § 3771) applies only to victims of the counts charged in federal court, and thus individuals may not be able to exercise all of these rights if the crime of which the individual is a victim was not charged. Section 3771(c)(2) of this Act requires that we advise you that you have the right to retain counsel. Although the statute specifically sets forth your right to seek advice of an attorney with regard to your rights under the statute, there is no requirement that you retain counsel. The Government may not recommend any specific counsel, nor can the Government (or the Court) pay for counsel to represent you. Government attorneys represent the United States.

If you elect to obtain counsel to represent your interests, please have your attorney notify this office in writing at: U.S. Department of Justice, Criminal Division, Fraud Section, 10th & Constitution Avenue, NW, Bond Building, 4th Floor, Washington, DC 20530, Attention: Victim Witness Unit; fax: (202) 514-3708; or email: If you elect not to retain counsel to represent your interests, you do not need to do anything.

Plea Agreements: Please be aware that many criminal cases are resolved by plea agreement between the Department of Justice and the defendant. You should also know that it is not unusual for a defendant to seek to negotiate a plea agreement shortly before trial is scheduled to begin. Plea agreements can be made at any time and as late as the morning of trial, leaving little or no opportunity to provide notice to you of the date and time of the plea hearing. If the court schedules a plea hearing in this case, we will use our best efforts to notify you of available information as soon as practicable. If you want to inform the prosecutor of your views regarding potential plea agreements, or any other aspect of the case, please contact the prosecutor assigned to this case or call the Victim Assistance Line toll-free at (888) 549-3945 or email us at

Updated September 27, 2023